Talk:Sartorius AG
This is the talk page for discussing improvements to the Sartorius AG article. This is not a forum for general discussion of the article's subject. |
Article policies
|
Find sources: Google (books · news · scholar · free images · WP refs) · FENS · JSTOR · TWL |
Archives: 1 |
This article is rated Start-class on Wikipedia's content assessment scale. It is of interest to the following WikiProjects: | ||||||||||||||||||||||||||||||||||||||
|
The Wikimedia Foundation's Terms of Use require that editors disclose their "employer, client, and affiliation" with respect to any paid contribution; see WP:PAID. For advice about reviewing paid contributions, see WP:COIRESPONSE.
|
Annual Report for 2023 available
editThe company has released its Annual Report for 2023 on February 16, 2024. Current sales revenue and employee figures are now available. (As of: December 31, 2023) https://www.sartorius.com/download/1519358/20240216-sag-pm-annual-report-2023-en-data.pdf
Suggested edits:
- Employees: 14,614 (End 2023)
- Sales Revenue: €3.4 bn (2023)
- Key people
* Alexandra Gatzemeyer, Ph.D., has been appointed as a member of the Executive Board of Sartorius AG effective May 1, 2023.
*Gerry Mackay has stepped down as Executive Board member as of June 16, 2023:https://www.eqs-news.com/de/news/corporate/sartorius-ag-alexandra-gatzemeyer-joins-executive-board-of-sartorius-to-lead-the-lab-products-services-division/1785607
*Rainer Lehmann has stepped down as CFO of Sartorius AG at the end of October 2023:https://www.boerse-muenchen.de/news/EQS199598/EQS-News_-SARTORIUS-AG_-Sartorius-announces-CFO-transition
*Dr. Florian Funck will join the Company as Chief Financial Officer (CFO) and member of the Executive Board, effective April 1, 2024:https://www.nasdaq.com/articles/sartorius-appoints-florian-funck-as-cfo
Joachim Kreuzburg (CEO & Executive Board Chair) René Fáber (Executive Board Member) Alexandra Gatzemeyer (Executive Board Member) Florian Funck (CFO, effective April 1, 2024)
Update based on Annual Report 2023
editThis edit request by an editor with a conflict of interest has now been answered. |
- What I think should be changed:
- Employees number: 14,614 (December 31, 2023)
- Sales Revenue: €3.4 bn (2023)
- Major changes in Key people need to be reflected:
- Joachim Kreuzburg (CEO & Executive Board Chair)
- René Fáber (Executive Board Member)
- Alexandra Gatzemeyer (Executive Board Member)
- Florian Funck (CFO)
Gerry Mackay (Executive Board Member)Rainer Lehmann (CFO)
- Why it should be changed:
There have been significant changes in the management of the company, which should be reflected on this page. The financial results have been updated and should be displayed correctly for a publicly listed company.
- Alexandra Gatzemeyer, Ph.D., has been appointed as a member of the Executive Board of Sartorius AG effective May 1, 2023.
- Gerry Mackay has stepped down as Executive Board member as of June 16, 2023.
- Rainer Lehmann has stepped down as CFO of Sartorius AG at the end of October 2023.
- Dr. Florian Funck joined the Company as Chief Financial Officer (CFO) and member of the Executive Board, effective April 1, 2024.
- References supporting the possible change :
- Gerry Mackay has stepped down as Executive Board member as of June 16, 2023. Alexandra Gatzemeyer, Ph.D., has been appointed as a member of the Executive Board of Sartorius AG effective May 1, 2023.[1]
- The company has released its Annual Report for 2023 on February 16, 2024. Updated sales revenue and employee figures are available.[2]
- Rainer Lehmann has stepped down as CFO of Sartorius AG at the end of October 2023. Dr. Florian Funck joined the Company as Chief Financial Officer (CFO) and member of the Executive Board, effective April 1, 2024.[3]
References
- ^ "SARTORIUS AG: Alexandra Gatzemeyer joins Executive Board of Sartorius to lead the Lab Products & Services division". eqs-news.com. Retrieved June 25, 2024.
- ^ "Sartorius Group 2023 Annual Report" (PDF). sartorius.com. Retrieved June 25, 2024.
- ^ "Sartorius Appoints Florian Funck As CFO". nasdaq.com. Retrieved June 25, 2024.
Andre at Sartorius (talk) 14:27, 25 June 2024 (UTC)
- Done @Andre at Sartorius:Thanks for the updates. I have updated the infobox. – robertsky (talk) 16:26, 9 July 2024 (UTC)
Edit error in info box
editThis edit request by an editor with a conflict of interest has now been answered. |
- What I think should be changed:
I would like to update the info box of the article to reflect the current Executive Board members. Please replace "Gerry Mackay" with "René Fáber", who has been a Member of the Executive Board since 2019.[1]
- Why it should be changed:
The current information is wrong.
References
- ^ "Sartorius AG: Alexandra Gatzemeyer joins Executive Board of Sartorius to lead the Lab Products & Services Division". eqs-news.com. Retrieved July 16, 2024.
Andre at Sartorius (talk) 13:38, 16 July 2024 (UTC)
- Done , though that source seems to imply a different board composition than the one in the infobox (is Rainer Lehmann on the board? why are they not in the infobox?). Rusalkii (talk) 20:12, 17 July 2024 (UTC)
- Er, just read the above edit request. Please ignore the above. Rusalkii (talk) 20:13, 17 July 2024 (UTC)
Proposed references for missing sources
editAn impartial editor has reviewed the proposed edit(s) and asked the editor with a conflict of interest to go ahead and make the suggested changes. |
- What I think should be changed:
There are several parts in the Recent History (since 2000) chapter of the article that have an indication that a citation is needed. These citations should be added to verify the article.
- Why it should be changed:
It should be changed to improve this article's verifiability.
- Specific text to be added or removed:
In the following, I will list the parts for which a citation is currently missing, and below them the suggested references.
2000
Sartorius took over B. Braun Biotech International (BBI) from B. Braun Melsungen AG. BBI, the world's leading manufacturer of fermenters (bioreactor) and cell culture systems at the time, was integrated into the Sartorius group as Sartorius Stedim Systems GmbH (formerly Sartorius BBI Systems GmbH ), a subsidiary of Sartorius Stedim Biotech GmbH.[citation needed]
- "B. Braun Biotech International GmbH". Life-Sciences-Europe.com - The European Life Sciences Web Portal. Retrieved 2024-10-25.
Sartorius AG acquired the remaining shares in Viva Science and is now the sole owner. [citation needed]
- "Sartorius erhöht Beteiligung an der Vivascien". GSC Research (in German). Retrieved 2024-10-25.
2005
Sartorius acquires 100% of the shares of Omnimark Instrument Corporation, Arizona, United States (moisture analyzers). [citation needed]
- "Sartorius acquires Omnimark". Manufacturing Chemist. Retrieved 2024-10-25.
2007
Sartorius took over the Toha Plast GmbH, which now operates under the name Sartorius Stedim Plastics. [citation needed]
- "Sartorius kauft Toha Plast GmbH - Technologiekonzern stärkt seine Position in der Kunststofftechnologie für biopharmazeutische Einwegprodukte". Chemie.de (in German). Retrieved 2024-10-25.
2008
Through its subgroup, SSB Sartorius acquired the Swiss-based Wave Biotech AG, a leading provider of single-use bioreactors. [citation needed]
- "Sartorius Stedim Biotech Acquires Wave Biotech". BioPharm International. Retrieved 2024-10-25.
2011
Sartorius acquired the liquid handling business of the Finnish laboratory specialists Biohit. Thus, the Group expands its product portfolio in the field of laboratory instruments. [citation needed]
- "Sartorius Concludes Agreement to Acquire the Liquid Handling Business of the Finnish Laboratory Supplier Biohit". Business Wire. Retrieved 2024-10-25.
Andre at Sartorius (talk) 09:13, 25 October 2024 (UTC)
- Thank you for your request above. Please feel free to go ahead and add the relevant citations.
- Kind regards, Axad12 (talk) 16:20, 25 October 2024 (UTC)
- Thank you for reviewing the suggested changes @Axad12. I will apply them shortly. Andre at Sartorius (talk) 17:15, 25 October 2024 (UTC)